Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating the correlation between Xrn1-resistant RNAs and frameshifter pseudoknots. | RNA Biol | 2023 | 37400999 | PubTator, text mining | PubMed |
| Nrf2 Drives Hepatocellular Carcinoma Progression through Acetyl-CoA-Mediated Metabolic and Epigenetic Regulatory Networks. | Mol Cancer Res | 2023 | 37364049 | PubTator, text mining | PubMed |
| Whole genome analysis of a novel Spodoptera exigua nucleopolyhedrovirus isolate (SeMNPV-IR) to Iran. | Biologia (Bratisl) | 2023 | 37363644 | PubTator, text mining | PubMed |
| Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. | Mol Cell Proteomics | 2023 | 37353004 | PubTator, text mining | PubMed |
| Squid express conserved ADAR orthologs that possess novel features. | Front Genome Ed | 2023 | 37342458 | PubTator, text mining | PubMed |
| Construction of a prognostic model based on genes associated with mitochondrial energy metabolic pathway in colon adenocarcinoma and its clinical significance. | J Mol Recognit | 2023 | 37322568 | PubTator, text mining | PubMed |
| Microbiological Safety and Quality of Fermented Products. | Foods | 2023 | 37297449 | PubTator, text mining | PubMed |
| Depletion of pyruvate kinase (PK) activity causes glycolytic intermediate imbalances and reveals a PK-TXNIP regulatory axis. | Mol Metab | 2023 | 37290673 | PubTator, text mining | PubMed |
| Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC. | Front Pharmacol | 2023 | 37284309 | PubTator, text mining | PubMed |
| Stress-responsive Gdf15 counteracts renointestinal toxicity via autophagic and microbiota reprogramming. | Commun Biol | 2023 | 37270567 | PubTator, text mining | PubMed |
| EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies. | Exp Hematol Oncol | 2023 | 37268997 | PubTator, text mining | PubMed |
| PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3β-N-nsp3 cascade. | J Med Virol | 2023 | 37264691 | PubTator, text mining | PubMed |
| NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37249337 | PubTator, text mining | PubMed |
| Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease. | Viruses | 2023 | 37243249 | PubTator, text mining | PubMed |
| Protein-Gene Orthology in Baculoviridae: An Exhaustive Analysis to Redefine the Ancestrally Common Coding Sequences. | Viruses | 2023 | 37243176 | PubTator, text mining | PubMed |
| Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase. | Pharmaceuticals (Basel) | 2023 | 37242451 | PubTator, text mining | PubMed |
| Green Synthesis of Aromatic Nitrogen-Containing Heterocycles by Catalytic and Non-Traditional Activation Methods. | Molecules | 2023 | 37241894 | PubTator, text mining | PubMed |
| Lactate mediated metabolic crosstalk between cancer and immune cells and its therapeutic implications. | Front Oncol | 2023 | 37234972 | PubTator, text mining | PubMed |
| Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma. | Front Immunol | 2023 | 37234166 | PubTator, text mining | PubMed |
| Cellular Alterations in Carbohydrate and Lipid Metabolism Due to Interactions with Nanomaterials. | J Funct Biomater | 2023 | 37233384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers?page=12